Nationale Nederlanden PTE – the largest institutional investor in the CEE region, joins the shareholder base of multiQure

News

Inquiries

PB004 project – efficacy and safety confirmed in in vivo models

31 July

2023

PB004 project – efficacy and safety confirmed in in vivo models

Preclinical proof of concept (PoC) of the ability to inhibit tumor growth in a human tumor model containing a molecular target (ROR-1) for candidate PBA-0405.

Pure Biologics meets terms of investment agreement with ACRX and completes strategic options review

30 May

2023

Pure Biologics meets terms of investment agreement with ACRX and completes strategic options review

The strategic options review process is completed.

PB004 project – lead candidate nominated

13 April

2023

PB004 project – lead candidate nominated

Lead candidate in project PB004 for further preclinical and clinical development - the molecule PBA-0405.

PB003G project – lead candidate nominated

5 April

2023

PB003G project – lead candidate nominated

Lead candidate in project PB004 for further preclinical and clinical development - the molecule PBA-0091.

Pure Biologics establishes Doto Medical special purpose vehicle

2 December

2022

Pure Biologics establishes Doto Medical special purpose vehicle

Pure Biologics establishes the Doto Medical special purpose vehicle and signs an agreement with the renowned international business advisor Clairfield Partners to accelerate the commercialization of the PB103 aptamer project.

Zapytanie Ofertowe – 00007/00008_ABM_02/2023

18 December

2023

Nationale Nederlanden PTE – the largest institutional investor in the CEE region, joins the shareholder base of multiQure

PB004 project – efficacy and safety confirmed in in vivo models

Pure Biologics meets terms of investment agreement with ACRX and completes strategic options review

PB004 project – lead candidate nominated

PB003G project – lead candidate nominated

Pure Biologics establishes Doto Medical special purpose vehicle

Zapytanie Ofertowe – 00007/00008_ABM_02/2023

Zapytanie Ofertowe – 00007/00008_ABM_01/2023

Zapytanie Ofertowe – PB/MAGBBRIS/0/5/20 09.10.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/4/20 17.06.2020

Zapytanie Ofertowe – PB/MAGBBRIS/0/3/20 10.04.2020